- Home
- L vs HOLX Comparison
L vs HOLX Comparison
Compare L & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- L
- HOLX
- Stock Information
- Founded
- L 1969
- HOLX 1985
- Country
- L United States
- HOLX United States
- Employees
- L N/A
- HOLX N/A
- Industry
- L Property-Casualty Insurers
- HOLX Medical Electronics
- Sector
- L Finance
- HOLX Health Care
- Exchange
- L Nasdaq
- HOLX Nasdaq
- Market Cap
- L 18.1B
- HOLX 16.3B
- IPO Year
- L N/A
- HOLX 1990
- Fundamental
- Price
- L $87.96
- HOLX $56.23
- Analyst Decision
- L
- HOLX Buy
- Analyst Count
- L 0
- HOLX 14
- Target Price
- L N/A
- HOLX $79.00
- AVG Volume (30 Days)
- L 669.9K
- HOLX 3.9M
- Earning Date
- L 05-05-2025
- HOLX 05-01-2025
- Dividend Yield
- L 0.28%
- HOLX N/A
- EPS Growth
- L N/A
- HOLX 25.36
- EPS
- L 6.09
- HOLX 2.39
- Revenue
- L $17,773,000,000.00
- HOLX $4,026,500,000.00
- Revenue This Year
- L N/A
- HOLX $3.34
- Revenue Next Year
- L N/A
- HOLX $5.43
- P/E Ratio
- L $14.43
- HOLX $23.19
- Revenue Growth
- L 8.71
- HOLX 1.66
- 52 Week Low
- L $73.15
- HOLX $51.90
- 52 Week High
- L $92.42
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- L 55.07
- HOLX 43.41
- Support Level
- L $85.10
- HOLX $51.90
- Resistance Level
- L $89.39
- HOLX $57.51
- Average True Range (ATR)
- L 1.52
- HOLX 1.53
- MACD
- L 0.26
- HOLX 0.01
- Stochastic Oscillator
- L 71.73
- HOLX 54.21
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.